BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients (Q36050710)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients |
scientific article |
Statements
1 reference
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients (English)
1 reference
Claude Preudhomme
1 reference
Frederic Luciano
1 reference
Thomas Cluzeau
1 reference
Guillaume Robert
1 reference
Nicolas Mounier
1 reference
Jean Michel Karsenti
1 reference
Maeva Dufies
1 reference
Alexandre Puissant
1 reference
Arnaud Jacquel
1 reference
Aline Renneville
1 reference
Jill-Patrice Cassuto
1 reference
Sophie Raynaud
1 reference
Patrick Auberger
1 reference
1 April 2012
1 reference
1 reference
490-501
1 reference
Identifiers
1 reference
1 reference